Article Details

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Buy" from Analysts

Retrieved on: 2021-10-11 09:33:45

Tags for this article:

Click the tags to see associated articles and topics

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

Lazard Asset Management LLC now owns 1,404 shares of the biotechnology company's stock worth $61,000 after purchasing an additional 1,354 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up